Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer

BACKGROUND: Gastric cancer (GC) is a heterogeneous disease, and is a leading cause of cancer deaths in Eastern Asia. Genomic analysis, such as whole-exome sequencing (WES), can help identify key genetic alterations leading to the malignancy and diversity of GC, and may help identify new drug targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhenxin, Fu, Hongbing, Wang, Shengzhou, Yu, Xinxin, You, Qing, Shi, Mengyao, Dai, Chun, Wang, Guan, Cha, Wei, Wang, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729362/
https://www.ncbi.nlm.nih.gov/pubmed/33313229
http://dx.doi.org/10.21037/atm-20-6620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729362/
https://www.ncbi.nlm.nih.gov/pubmed/33313229
http://dx.doi.org/10.21037/atm-20-6620

Ejemplares similares